ACTIVE

TAKEDA BELGIUM

Export PDF

Financial year 2025 · closed on 31/03/2025

Net result

4,2 M €

-61.9% YoY

Revenue

201,4 M €

+12.0% YoY

Equity

52,6 M €

+8.6% YoY

Workforce

78,6 ETP

+2.9% YoY

What does TAKEDA BELGIUM do?

TAKEDA BELGIUM is a Public limited company incorporated in 1945. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Zaventem. It employs on average 78,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0403.054.202

Incorporation

11/06/1945

Legal form

Public limited company

Registered office

Da Vincilaan 7
1930 Zaventem · FlandreSee on map

Contributed capital

5 577 855,00 €

Latest accounts

31/03/2025

Average workforce

78,6 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport 70200Management consultancy activities 70220Business and other management consultancy activities 74142Specialised design activities

Joint committees (3)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 15 financial years

	2025		2024		2023		2022		2019		2018		2017		2016		2015		2014		2013		2012		2010		2009		2008
Income statement
Revenue	201,4 M €	+12.0%	179,9 M €	+12.2%	160,4 M €	+13.6%	141,2 M €	+2.3%	138 M €	+6.2%	129,9 M €	-5.3%	137,2 M €	+57.2%	87,3 M €	-5.3%	92,1 M €	+5.4%	87,4 M €	+3.2%	84,7 M €	-22.9%	109,8 M €	+38.7%	79,2 M €	+0.2%	79,1 M €	-13.0%	90,9 M €
EBITDA	6,9 M €	-58.6%	16,5 M €	+82.7%	9 M €	+3.7%	8,7 M €	-57.8%	20,7 M €	-1.7%	21 M €	-44.7%	38 M €	+116%	17,6 M €	+432%	-5,3 M €	-163%	8,4 M €	-21.1%	10,7 M €	-3.7%	11,1 M €	+19.3%	9,3 M €	+7.3%	8,7 M €	-47.3%	16,4 M €
Operating result	6,4 M €	-59.3%	15,7 M €	+104%	7,7 M €	+8.0%	7,1 M €	-64.1%	19,9 M €	-1.8%	20,3 M €	-45.4%	37,1 M €	+142%	15,3 M €	+317%	-7,1 M €	-212%	6,3 M €	-31.7%	9,2 M €	-3.9%	9,6 M €	+17.8%	8,1 M €	+9.0%	7,4 M €	-51.1%	15,2 M €
Net result	4,2 M €	-61.9%	10,9 M €	+99.7%	5,5 M €	+15.0%	4,8 M €	-64.1%	13,3 M €	-3.1%	13,7 M €	-50.8%	27,9 M €	+151%	11,1 M €	+251%	-7,3 M €	-276%	4,2 M €	-19.3%	5,2 M €	+23.1%	4,2 M €	+67.7%	2,5 M €	-22.3%	3,2 M €	-53.3%	6,9 M €
Balance sheet
Equity	52,6 M €	+8.6%	48,4 M €	+29.2%	37,5 M €	+17.1%	32 M €	-36.0%	50 M €	+36.2%	36,7 M €	0.0%	36,7 M €	-32.0%	53,9 M €	+25.9%	42,8 M €	-14.6%	50,2 M €	+9.1%	46 M €	+324%	10,9 M €	+62.9%	6,7 M €	+0.1%	6,7 M €	-0.5%	6,7 M €
Total assets	82,7 M €	+10.6%	74,8 M €	+9.3%	68,4 M €	-0.9%	69,1 M €	-9.4%	76,2 M €	+8.3%	70,4 M €	-44.1%	126 M €	+53.7%	82 M €	+2.9%	79,7 M €	-3.2%	82,3 M €	+10.8%	74,3 M €	-6.8%	79,8 M €	-1.0%	80,6 M €	-47.8%	154,3 M €	-7.0%	165,9 M €
Cash	88 k €	+8.0%	81,5 k €	+3539%	2,2 k €	+869%	231,2 €		–		–		17,3 k €	+5.2%	16,5 k €	-26.9%	22,5 k €	+44.0%	15,6 k €	+60.3%	9,8 k €	-65.5%	28,3 k €	-87.2%	220,3 k €	-96.3%	5,9 M €	+23.3%	4,8 M €
Debts	30 M €	+14.5%	26,2 M €	-14.8%	30,8 M €	-16.4%	36,8 M €	+43.3%	25,7 M €	-21.8%	32,8 M €	-62.0%	86,3 M €	+242%	25,3 M €	+44.5%	17,5 M €	-43.2%	30,8 M €	+17.5%	26,2 M €	-61.4%	67,8 M €	-7.2%	73,1 M €	-50.1%	146,4 M €	-7.1%	157,7 M €
Other
Workforce	78,6 ETP	+2.9%	76,4 ETP	+0.1%	76,3 ETP	-5.3%	80,6 ETP	-4.7%	84,6 ETP	+0.4%	84,3 ETP	-4.9%	88,6 ETP	+29.9%	68,2 ETP	-42.7%	119,1 ETP	-7.7%	129,1 ETP	-3.7%	134,0 ETP	+4.3%	128,5 ETP	-5.1%	135,4 ETP	-2.1%	138,3 ETP	-2.9%	142,4 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/03/2025 · 4 active · 16 ended

Active mandates

Bruno Rabillier

Managing director · since 01 septembre 2024 · until 26 septembre 2029

Active

Aline Vandecappelle

Director · since 01 novembre 2023 · until 26 septembre 2029

Active

Michael Nesrallah

Director · since 07 mars 2022 · until 27 juin 2024

Active

Paul De Proft

Director · since 31 mars 2020

Active

Ended mandates

Aline Vandelapelle

Director · since 01 novembre 2023 · until 26 septembre 2029

Ended

Michael Nesrallah

Director · since 07 mars 2022 · until 29 septembre 2027

Ended

Takeda Pharmaceutical International AG

Director · since 15 avril 2020

Represented by Peter Stossel

Ended

Elke Pitomvils

Director · since 31 mars 2020 · until 01 novembre 2023

Ended

At this address

Other companies at this address

Company	CBE no.
FORCEA● Active	0883.520.342
IM ASSOCIATES● Active	0464.554.477
IQVIA Cancer Research● Active	0763.914.095
IQVIA RDS & INTEGRATED SERVICES BELGIUM● Active	0459.151.577
IQVIA Solutions Belgium● Active	0400.502.211
Orifarm Healthcare● Active	0755.731.948
REDPHARMA● Active	0824.819.011

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/04/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020	01/04/2019
Closing of the financial year	31/03/2025	31/03/2024	31/03/2023	31/03/2022	31/03/2021	31/03/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	09/10/2025	30/09/2024	16/10/2023	04/10/2022	04/10/2021	16/11/2020
General meeting	24/09/2025	25/09/2024	27/09/2023	28/09/2022	29/09/2021	23/10/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/03/2025	24/09/2025	09/10/2025	Dutch	PDF
Full model	31/03/2024	25/09/2024	30/09/2024	Dutch	PDF
Full model	31/03/2023	27/09/2023	16/10/2023	Dutch	PDF
Full model	31/03/2022	28/09/2022	04/10/2022	Dutch	PDF
Full model	31/03/2021	29/09/2021	04/10/2021	Dutch	PDF
Full model	31/03/2020	23/10/2020	16/11/2020	Dutch	PDF
Full model	31/03/2019	25/09/2019	18/10/2019	Dutch	PDF
Full model	31/03/2018	28/09/2018	05/10/2018	Dutch	PDF
Full model	31/03/2017	06/10/2017	12/10/2017	Dutch	PDF
Full model	31/03/2016	24/08/2016	14/09/2016	French	PDF
Full model	31/03/2015	30/09/2015	21/10/2015	French	PDF
Full model	31/03/2014	02/07/2014	14/07/2014	French	PDF
Full model	31/03/2013	03/07/2013	15/07/2013	French	PDF
Full model	31/03/2012	04/07/2012	10/07/2012	French	PDF
Full model	31/12/2010	04/05/2011	27/05/2011	French	PDF
Full model	31/12/2009	05/05/2010	01/06/2010	French	PDF
Full model	31/12/2008	06/05/2009	02/06/2009	French	PDF
Full model	31/12/2007	22/05/2008	16/06/2008	French	PDF
Full model	31/12/2006	02/05/2007	11/06/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 4 active · 16 ended

Active mandates

Bruno Rabillier

Managing director · since 01 septembre 2024 · until 26 septembre 2029

Active

Aline Vandecappelle

Director · since 01 novembre 2023 · until 26 septembre 2029

Active

Michael Nesrallah

Director · since 07 mars 2022 · until 27 juin 2024

Active

Paul De Proft

Director · since 31 mars 2020

Active

Ended mandates

Aline Vandelapelle

Director · since 01 novembre 2023 · until 26 septembre 2029

Ended

Michael Nesrallah

Director · since 07 mars 2022 · until 29 septembre 2027

Ended

Takeda Pharmaceutical International AG

Director · since 15 avril 2020

Represented by Peter Stossel

Ended

Elke Pitomvils

Director · since 31 mars 2020 · until 01 novembre 2023

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates18/12/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/11/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/01/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/09/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/07/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates22/11/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates31/10/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/04/2022
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

25/09/2025
reconductionPaul DE PROFT — bestuurder
25/09/2025
unknownVANDECAPPELLE Aline — bestuurder
25/09/2025
unknownRABILIER Bruno — bestuurder en gedelegeerd bestuurder
2025
Annual accounts 20254,2 M €↓
01/01/2025
nominationBruno Rabilier — gedelegeerd bestuurder
01/09/2024
nominationBruno Rabilier — bestuurder
01/09/2024
unknownPaul De Proft — bestuurder en gedelegeerd bestuurder
01/09/2024
unknownAline Vandecappelle — bestuurder
2024
Annual accounts 202410,9 M €↑
01/11/2023
nominationAline Vandecappelle — bestuurder
27/09/2023
reconductionKPMG Bedrijfsrevisoren BV — commissaris
2023
Annual accounts 20235,5 M €↑
2022
Annual accounts 20224,8 M €↓
07/03/2022
revocationPaul de Proft — machten van dagelijks bestuur
2019
Annual accounts 201913,3 M €↓
2018
Annual accounts 201813,7 M €↓
2017
Annual accounts 201727,9 M €↑
2016
Annual accounts 201611,1 M €↑
2015
Annual accounts 2015-7,3 M €↓
2014
Annual accounts 20144,2 M €↓
2013
Annual accounts 20135,2 M €↑
2012
Annual accounts 20124,2 M €↑
2010
Annual accounts 20102,5 M €↓
2009
Annual accounts 20093,2 M €↓
2008
Annual accounts 20086,9 M €
11/06/1945
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

TAKEDA BELGIUM

Overview

What does TAKEDA BELGIUM do?

Trend over 15 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline